EMA Withdrawn: Clopidogrel ratiopharm GmbH (clopidogrel) — Archie Samiel s.r.o.

View source ↗

Summary

EMA withdrew clopidogrel from Archie Samiel s.r.o.'s product line, with therapeutic areas including peripheral vascular diseases, acute coronary syndrome, myoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases;Acute Coronary Syndrome;Myocardial Infarction;Stroke. MAH: Archie Samiel s.r.o.. Decision date: 22/08/2019